Neuropsychopharmacology
- Development of the McLean Hospital MENTOR Program to enhance mental health career pathways7 months ago
- Changes in nucleus accumbens core translatome accompanying incubation of cocaine craving7 months ago
- A rat model of volitional mutual social interactions8 months ago
- Comparing neuromodulation targets to reduce cigarette craving and withdrawal: a randomized clinical trial8 months ago
- Associations between structural brain measures and cognitive function in bipolar disorder: a systematic review and meta-analysis8 months ago
- Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia8 months ago
- Effects of methamphetamine on two measures of reward: Euphoria and neural activation to reward cues8 months ago
Journal of Psychopharmacology
- Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies1 year ago
- Co-use of psychedelics with other substances: Findings from the global psychedelic survey1 year ago
- Effects of positive mGlu5 modulation on D2 signaling and nicotine-conditioned place preference: Mechanisms of epigenetic inheritance in a transgenerational model of drug abuse vulnerability in psychosis1 year ago
- Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment1 year ago
- The impact of cannabidiol placebo on amygdala-based neural responses to an acute stressor1 year ago
- Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm1 year ago
- Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial1 year ago
European Neuropsychopharmacology
- Towards a consensus roadmap for a new diagnostic framework for mental disorders1 year ago
- Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses1 year ago
- A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder1 year ago
- Lung function decline in people with serious mental illness: A call to action1 year ago
- Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker1 year ago
- Pioglitazone attenuates behavioral and electrophysiological dysfunctions induced by two-hit model of schizophrenia in adult rodent offspring1 year ago
- Psychiatric first-aid kit: A review of EMA’s critical medicines list1 year ago